About 14,055 results

ALLMedicine™ Mood Disorders Center

Research & Reviews  4,440 results

Trajectories of adolescent psychotic-like experiences and early cannabis exposure: Resu...
Schizophrenia Research; Denissoff A, Mustonen A et. al.

Jun 27th, 2022 - Longitudinal studies examining the effect of cannabis exposure (CE) on the prognosis of adolescents with psychotic-like experiences (PLEs) are scarce. We examined trajectories of mental health in adolescents with PLEs and cannabis exposure. The No...

A retrospective examination of adjunctive L-methylfolate in children and adolescents wi...
Journal of Affective Disorders; Bopp EA, Poweleit EA et. al.

Jun 27th, 2022 - Adjunctive l-methylfolate is commonly prescribed for children and adolescents with treatment-resistant mood disorders; however, the relationship between l-methylfolate augmentation across methylenetetrahydrofolate reductase (MTHFR) genotypes in yo...

Sexual Function and Mood Disorders Among Menopausal Women: A Systematic Scoping Review.
The Journal of Sexual Medicine; Rahmani A, Afsharnia E et. al.

Jun 26th, 2022 - Changes in sex hormones during menopause may have detrimental effects on a woman's sexual function and cause mood disorders. The treatment of both conditions is a challenge in gynecology. To review the published literature on sexual function and m...

Sleep and affective disorders in relation to Parkinson's disease risk among older women...
Journal of Affective Disorders; Beydoun HA, Chen JC et. al.

Jun 26th, 2022 - To evaluate sleep and affective (mood/anxiety) disorders as clinical predictors of incident Parkinson's disease (PD) among women ≥65 years of age. We performed secondary analyses with available data from the Women's Health Initiative Clinical Tria...

see more →

Guidelines  7 results

Mapping a rapidly changing landscape - Guidance on digital health interventions and the...
Bipolar Disorders; Morton E

Apr 1st, 2021 - Mapping a rapidly changing landscape - Guidance on digital health interventions and the Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood Disorders.|2021|Morton E,|diagnosis,therapy,

ACOG Committee Opinion No. 757: Screening for Perinatal Depression.
Obstetrics and Gynecology;

Jan 11th, 2019 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on...

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the...
Journal of Clinical Oncology : Official Journal of the Am... Lyman GH, Greenlee H et. al.

Jun 12th, 2018 - Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO)...

Adolescent Pregnancy Guidelines.
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Fleming N, O'Driscoll T et. al.

Oct 17th, 2015 - To describe the needs and evidence-based practice specific to care of the pregnant adolescent in Canada, including special populations. Healthy pregnancies for adolescent women in Canada, with culturally sensitive and age-appropriate care to ensur...

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendation...
Annals of Clinical Psychiatry : Official Journal of the A... Beaulieu S, Saury S et. al.

Feb 4th, 2012 - Mood disorders, especially bipolar disorder (BD), frequently are associated with substance use disorders (SUDs). There are well-designed trials for the treatment of SUDs in the absence of a comorbid condition. However, one cannot generalize these ...

see more →

Drugs  46 results see all →

Clinicaltrials.gov  427 results

Long-term Observation of Participants With Mood Disorders

Jun 24th, 2022 - Synopsis Title: Long-term Observation of Participants with Mood Disorders Study Description: The proposal will leverage existing data on former participants with mood disorders collected in the Experimental Therapeutics and Pathophysiology Branch ...

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Jun 24th, 2022 - OBJECTIVE Modulation of glutamatergic signaling is implicated in improvement of depressive symptoms and related constructs/dimensions of observable behavior and neurobiological measures with treatment. Current standard monoaminergic pharmacologica...

Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression

Jun 24th, 2022 - OBJECTIVE: During the perimenopause, the incidence of depression increases 1-5 and predicts increased all-cause and cardiovascular mortality. A role of estradiol withdrawal in the onset of mood disorders in some perimenopausal women has been sugge...

Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes

Jun 24th, 2022 - Objective: This protocol uses functional magnetic resonance imaging (fMRI) to examine neuro-cognitive correlates of pediatric and adult mood and anxiety disorders. The primary goal of the project is to document, in pediatric anxiety disorders and ...

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

Jun 24th, 2022 - The purpose of this protocol is to allow for the careful screening of patients and healthy volunteers for participation in research protocols on mood and anxiety disorders at the National Institute of Mental Health (NIMH) and for the collection of...

see more →

News  681 results

Knowledge gaps and challenges in care for menopausal women
JoAnn Pinkerton, MD, NCMP

Jun 9th, 2022 - The transition to menopause begins with ovarian fluctuation and hormonal changes, often beginning before significant changes in menstruation. Reproductive aging with loss of follicular activity progresses over a wide age range (42 to 58 years) wit.

Managing Mental Health and Substance Abuse In HIV Patients

Jun 7th, 2022 - This transcript has been edited for clarity. Michael Saag, MD: Hello. I'm Dr Michael Saag, and welcome to Medscape InDiscussion: HIV. Today we're talking about managing mental health and substance abuse in patients with HIV. I picked this topic be...

'Alarming' New Data on Disordered Sleep After COVID

Jun 7th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Moderate to severe sleep disturbances and severe fatigue affect up to 40% of patients with long COVID, or post-acute sequelae of SARS-CoV-2 infect...

Commentary: New Prognostic Markers in Rheumatoid Arthritis, June 2022
Arundathi Jayatilleke, MD

Jun 1st, 2022 - Arundathi Jayatilleke, MD Predicting severe disease is of great importance in rheumatoid arthritis (RA), ideally to establish which poor prognostic factors allow for early aggressive and targeted treatment for a subset of patients. In a post hoc a.

see more →

Patient Education  21 results see all →